english.prescrire.org > Prescrire International > N°168 - February 2016

n°168

February 2016

Issue Contents
Editorial

Free  Fight inertia!

p.32
Massive quantities of oseltamivir have been sold, despite a lack of evidence about its efficacy

Marketing Authorisations

Ospemifene (Senshio°)

p.33
More dangerous than helpful for women with postmenopausal vulvovaginal disorders

Unexpected benefit

p.34
Editors' opinion

Teduglutide (Revestive°)

p.34-35
For patients requiring permanent parenteral nutrition for short bowel syndrome

INN common stem: -navir

p.35

Denosumab (Prolia°) and male osteoporosis

p.36
Do not use in men (or in women)

Sorafenib (Nexavar°) and differentiated thyroid cancer

p.37
Toxic, and no proof of improved survival

Pasireotide (Signifor°) in acromegaly

p.38-39
After treatment failure: better than pegvisomant

Paracetamol + opium (Izalgi°) higher-dose for oral administration

p.39
A poor choice for analgesia

Insulin lispro (Humalog KwikPen°) double concentration 200 units/ml

p.40
Risk of confusion

Adverse Effects

Thiocolchicoside: review of adverse effects

p.41-43
No justification to use this drug

Thiocolchicoside: closely related to colchicine

p.42

Bismuth: more cases of encephalopathy

p.43
Expected toxicity

Tramadol: respiratory depression in a child

p.44
Overdose due to ultrarapid CYP2D6 metabolism

Tramadol: hypoglycaemia

p.44
Patients should be warned about the risk

Tramadol: hyponatraemia

p.44
Increased risk of hospital admission

Reviews

"Weak" opioid analgesics

p.45-51
Codeine, dihydrocodeine and tramadol: no less risky than morphine

Complex analgesic actions of opioids

p.47

Pregnancy: morphine, or sometimes buprenorphine, when paracetamol is ineffective

p.49

Influenza vaccination during pregnancy

p.51
Partial protection of mothers and infants

Outlook

Oseltamivir and influenza: still no robust data

p.52-55
No reason to recommend its widespread use

Oseltamivir for influenza, from birth: no more useful than in adults

p.53

Free  Oseltamivir: over 15 years of data retention and systematic stonewalling

p.55

Masthead

Free  Masthead

p.30

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe